Archeon Medical

Besançon-based medical device company behind EOlife, a real-time ventilation feedback device used during cardiac arrest resuscitation.

Industry
medical devices, emergency ventilation monitoring
Location
Besançon, France
Founded
2018

About

Archeon Medical makes EOlife, a real-time ventilation feedback device designed to improve survival and neurological outcomes in cardiac arrest resuscitation. Dealroom reports that the device measures the air volume delivered to a patient's lungs and guides responders to avoid over- and under-ventilation, and that the company holds FDA clearance and CE mark approval.

L'Est Républicain reports that the company was created in 2018, employs 25 people and has a subsidiary in New York. The company says the Series A will fund US clinical validation and commercial scale-up.

Funding history

RoundDateAmountLead
Series A 20262026-10-06$9MNewfund

Investors

Sources

Last verified:

  1. https://ala.associates/funding/archeon-medical-secures-9m-e7-5m-series-a-to-advance-clinical-validation-of-ventilation-system-for-cardiac-arrest-patients/
    Type: funding announcement. Accessed 2026-10-06.
    Company press release dated October 6, 2026, published by Andrew Lloyd and Associates. Announces $9 million (€7.5M) in Series A equity funding led by Newfund through its HEKA fund.
  2. https://dealroom.co/news/160232-archeon-medical-raises-7-5-million-to-push-eolife-into-us-market/
    Type: other verified public source. Accessed 2026-10-06.
    Dealroom News item dated 2026-10-06. Confirms the €7.5 million Series A, the Newfund lead and the participants, and names CEO Alban de Luca.
  3. https://www.estrepublicain.fr/economie/2026/10/06/la-start-up-bisontine-archeon-medical-leve-7-5-millions-d-euros-pour-se-developper-aux-etats-unis
    Type: reputable publication. Accessed 2026-10-06.
    L'Est Républicain article dated 2026-10-06, in French. Source of the 2018 founding year and the US subsidiary in New York.
  4. https://www.finsmes.com/2026/10/archeon-medical-raises-9m-in-series-a-funding.html
    Type: reputable publication. Accessed 2026-10-06.
    FinSMEs article dated 2026-10-06. Confirms the amount, stage, lead and participants.